September 12, 2022
Technology from a University of Cincinnati Venture Lab-backed startup could save lives by allowing emergency medical personnel to accurately monitor the life-saving treatment they provide.
October 7, 2022
A University of Cincinnati Venture Lab-backed startup is developing a breast cancer treatment that may be more effective with fewer side effects thanks to RNA nanotechnology that is similar to what was used to produce COVID-19 vaccines.
February 9, 2024
Founders of Cincinnati-based Genexia developed artificial intelligence to diagnose coronary artery disease risk during a mammogram — providing women with an important additional preventative diagnostic health marker.